Go Pro

Actuate Therapeutics (ACTU) Institutional Ownership

Actuate Therapeutics logo
$1.52 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$1.57 +0.05 (+3.29%)
As of 07/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Actuate Therapeutics (NASDAQ:ACTU)

Number of
Institutional Buyers
(last 12 months)
20
Total
Institutional Inflows
(last 12 months)
$11.65M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$341.34K
Get ACTU Insider Trade Alerts

Want to know when executives and insiders are buying or selling Actuate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ACTU Institutional Buying and Selling by Quarter

Actuate Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2026Royal Bank of Canada22,225$61K0.0%-37.0%0.094%
5/16/2026ABS Direct Equity Fund LLC50,000$137K0.1%+657.9%0.211%
2/18/2026Bridgeway Capital Management LLC30,982$190K0.0%N/A0.133%
2/17/2026Royal Bank of Canada35,263$215K0.0%+172.2%0.152%
2/16/2026Barclays PLC14,946$91K0.0%+68.6%0.064%
2/13/2026Charles Schwab Investment Management Inc.23,841$146K0.0%+61.5%0.103%
2/13/2026State Street Corp56,290$344K0.0%+12.8%0.242%
2/13/2026Voss Capital LP1,300,000$7.96M0.4%+45.0%5.594%
2/13/2026Wells Fargo & Company MN20,146$123K0.0%+48.8%0.087%
2/12/2026Jane Street Group LLC16,625$102K0.0%N/A0.072%
2/11/2026Deutsche Bank AG9,309$57K0.0%+640.0%0.040%
2/11/2026LPL Financial LLC12,965$79K0.0%-20.0%0.056%
2/10/2026Sfmg LLC20,000$122K0.0%+17.6%0.086%
2/10/2026Rock Creek Group LP21,759$133K0.0%N/A0.094%
2/9/2026Geode Capital Management LLC207,744$1.27M0.0%+42.9%0.894%
2/9/2026Texas Capital Bank Wealth Management Services Inc94,592$579K0.0%N/A0.407%
1/30/2026ABS Direct Equity Fund LLC6,597$40K0.0%N/A0.028%
11/20/2025Voss Capital LP896,278$6.00M0.3%+213.2%3.857%
11/17/2025Bank of America Corp DE4,872$33K0.0%-68.1%0.021%
11/12/2025BIOS Capital Management LP10,049,996$67.23M75.6%+0.9%43.244%
11/7/2025Vanguard Group Inc.316,010$2.11M0.0%+19.5%1.360%
11/3/2025New York State Common Retirement Fund6,200$41K0.0%-64.0%0.027%
10/29/2025Northwestern University6,488$43K0.1%-76.6%0.028%
8/15/2025Bank of America Corp DE15,292$93K0.0%+61,068.0%0.075%
8/14/2025Voss Capital LP286,140$1.75M0.1%+101.0%1.398%
8/13/2025New York State Common Retirement Fund17,200$105K0.0%N/A0.084%
8/13/2025Northwestern Mutual Wealth Management Co.18,518$113K0.0%+492.6%0.090%
8/12/2025BIOS Capital Management LP9,965,079$60.89M83.9%+0.7%48.681%
8/12/2025Sfmg LLC14,550$89K0.0%+32.3%0.071%
8/8/2025Geode Capital Management LLC118,050$721K0.0%+252.5%0.577%
7/17/2025Gleason Group Inc.19,028$116K0.0%N/A0.097%
6/27/2025Goldman Sachs Group Inc.22,358$151K0.0%+98.7%0.114%
5/16/2025Goldman Sachs Group Inc.22,358$151K0.0%+98.7%0.114%
5/14/2025Voss Capital LP142,381$964K0.1%+157.7%0.729%
5/9/2025Chicago Partners Investment Group LLC10,365$70K0.0%N/A0.053%
5/9/2025Sfmg LLC11,000$74K0.0%N/A0.056%
5/2/2025Sigma Planning Corp23,675$160K0.0%+47.3%0.121%
2/17/2025OMERS ADMINISTRATION Corp10,583$84K0.0%N/A0.054%
2/14/2025Mercer Global Advisors Inc. ADV16,344$130K0.0%N/A0.084%
2/14/2025Voss Capital LP55,246$440K0.0%N/A0.283%
Stranded On The Flood Plains of History (Ad)

The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.tc pixel

Read Porter's full briefing and get the ticker names today
2/13/2025Envestnet Asset Management Inc.10,465$83K0.0%N/A0.054%
2/10/2025BIOS Capital Management LP9,893,651$78.75M83.7%N/A50.659%
2/6/2025Freestone Capital Holdings LLC10,000$80K0.0%N/A0.051%
2/3/2025Sigma Planning Corp16,075$128K0.0%N/A0.082%
11/12/2024Northwestern University27,778$207K0.2%N/A0.142%
10/29/2024KG&L Capital Management LLC12,000$89K0.0%N/A0.061%


ACTU Institutional Ownership - Frequently Asked Questions

During the previous two years, 30 institutional investors and hedge funds held shares of Actuate Therapeutics. The most heavily invested institutionals were BIOS Capital Management LP ($67.23M), Voss Capital LP ($7.96M), Vanguard Group Inc. ($2.11M), Geode Capital Management LLC ($1.27M), Texas Capital Bank Wealth Management Services Inc ($579K), State Street Corp ($344K), and Bridgeway Capital Management LLC ($190K).Learn more on Actuate Therapeutics' institutional investors.

Of the 29 institutional investors that purchased Actuate Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($10.05M), Voss Capital LP ($1.30M), Geode Capital Management LLC ($146.89K), Texas Capital Bank Wealth Management Services Inc ($94.59K), Vanguard Group Inc. ($51.55K), ABS Direct Equity Fund LLC ($50K), and Bridgeway Capital Management LLC ($30.98K).

Institutional investors have bought a total of 1,858,315 shares in the last 24 months. This purchase volume represents approximately $11.65M in transactions.

The following institutional investors have sold Actuate Therapeutics stock in the last 24 months: Northwestern University ($21.29K), Royal Bank of Canada ($13.04K), New York State Common Retirement Fund ($11K), Bank of America Corp DE ($10.42K), and LPL Financial LLC ($3.25K).

Institutional investors have sold a total of 58,998 shares in the last 24 months. This volume of shares sold represents approximately $341.34K in transactions.



This page (NASDAQ:ACTU) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners